Titan Eyeplus’ Insight into Preventive Eye Care Awareness

Industry & Competitive Context

India's eyewear market has historically been dominated by small, independent, unbranded opticians rather than organized retail chains. Industry estimates place the unorganized segment's share of the market at roughly 70 percent, with organized players such as Titan Company, Lenskart, GKB Opticals, and Bausch & Lomb competing for the branded segment. Independent market-sizing reports place the value of the India eyewear market anywhere between roughly USD 6 billion and USD 10 billion as of 2023, with most forecasts projecting high single-digit to low double-digit compound annual growth through the early 2030s, driven by rising screen time, an aging population, and increasing fashion consciousness around spectacles.

A defining structural feature of this market, repeatedly cited in industry commentary, is the gap between the prevalence of vision problems and the rate at which they are diagnosed or corrected. This gap creates the strategic opening that preventive eye care campaigns are designed to close: the opportunity is not merely to sell spectacles to people who already know they need them, but to convert an undiagnosed population into aware, diagnosed customers.

Titan entered this fragmented category in 2007 through Titan Eyeplus, a wholly owned division of Titan Company Limited (a Tata Group joint venture with the Tamil Nadu Industrial Development Corporation). Titan Company's other divisions Tanishq in jewellery and Titan/Fastrack in watches had already established the parent as India's dominant organized-retail lifestyle player, giving Titan Eyeplus a trusted institutional heritage to draw on in a category where consumer trust in service quality and diagnostic accuracy was historically low.

Brand Situation Prior to Campaign

By the time of its major preventive-care awareness pushes, Titan Eyeplus had scaled to a large national retail footprint Titan Company's FY24 annual report update cited over 900 Titan Eyeplus stores in India along with a handful of international locations, and the company's investor communications describe the Eyecare Division as a double-digit-growth contributor within the group, with a Total Income of approximately ₹796 crore in FY25 as reported in Titan's own investor presentation. This places Titan Eyeplus as one of the largest organized eyewear retailers in the country by store count, operating alongside CSR-linked preventive health initiatives — grouped under Titan's "Happy Eyes" programme that the company has run since 2013 in partnership with Sankara Eye Foundation and other eye-hospital partners.

Despite this scale, the brand's own public communications point to a persistent underlying problem: large numbers of people with correctable vision impairment do not know they need correction. In one brand-commissioned study covering roughly 11,000 people in Bengaluru, referenced in the brand's 2021 World Sight Day communication, 58 percent of respondents were found to need vision correction, but only 36 percent were aware of or already using corrective eyewear. This is the specific "awareness gap" rather than an access or affordability gap alone that Titan Eyeplus's subsequent campaigns were built to address.

Strategic Objective

Across its publicly documented initiatives, Titan Eyeplus's stated strategic objective is consistent: to convert eye care from a low-priority, reactive category into a routine, preventive health behavior among specific under-screened population segments, while reinforcing the brand's positioning as India's most trusted, expert-led eye care provider rather than merely a spectacles retailer. Distinct campaigns have targeted distinct segments of this broader objective the general urban population (2021 Duochrome/World Sight Day initiative), commercial truck drivers (2024 "Eye Test Menu"), school-going children (2025 "Ek Tara Test" and the GEMS Education partnership in the UAE), and rural and economically disadvantaged communities (the long-running Happy Eyes CSR programme). In each case, the stated goal in company and agency communications is screening and diagnosis at scale, positioned as a precursor to, rather than a direct pitch for, a sales transaction.

Campaign Architecture & Execution

World Sight Day 2021 — the Duochrome self-screening film. Timed to World Sight Day, Titan Eyeplus released a digital video featuring brand ambassador Ayushmann Khurrana, conceptualized by Ogilvy, that encouraged viewers to take a digitized version of the brand's in-store Duochrome eye test one of the 20 diagnostic steps used in a full Titan Eyeplus eye examination online and unaided. The stated ambition, per the brand's own release, was to achieve a Guinness World Record for the highest number of digital eye screenings 10 million within a two-month window. The mechanic is notable strategically because it converts a proprietary in-store diagnostic asset into a free, shareable, mass-reach digital tool, using a category-relevant celebrity (Khurrana, known partly for eyewear-associated public image) as the amplification vehicle.

"Eye Test Menu" (2024) reaching truck drivers at the point of need. For World Sight Day 2024, under the campaign theme "Make Indian Roads Safe," Titan Eyeplus and Ogilvy built an initiative around the finding attributed publicly to a "Bridging Vision Gaps" report dated April 2024 that roughly one in three Indian truck drivers has compromised vision, a population that the Ministry of Road Transport and Highways' 2022 data links to over 25,000 truck- and lorry-related accidents and more than 10,000 fatalities annually in India. Rather than asking drivers to visit a store, the brand set up free eye-test camps at dhabas (highway roadside eateries) where drivers stop to eat, presenting the screening as an "Eye Test Menu" alongside the food menu, conducted on the spot by optometrists. Public reporting on the initiative describes a structured follow-through: screening was paired with free eye tests, prescribed corrective spectacles, a choice of frames, and subsidised home delivery of glasses to encourage drivers to actually use and keep the corrective eyewear rather than lose or discard it on the road. Company statements report that since June 2024, Titan Eye+ had screened over 7,000 drivers across more than 900 locations, with a stated ambition to extend testing to over 100,000 (1 lakh) drivers through further partnerships.

"Ek Tara Test" (2025) reframing paediatric screening as play. For children, Titan Eyeplus and Ogilvy South launched the "Ek Tara Test," built around a revived version of the classic astronomical "Hunter's Test" the ability to distinguish two closely spaced stars in the Mizar–Alcor pair within the Great Bear (Saptarishi) constellation, historically used informally to test visual acuity. The brand distributed a glow-in-the-dark transparent card that turns stargazing into a game for parents and children, framed publicly around the stated statistic that one in five children is affected by blurry vision, many without visible symptoms, positioning the exercise as a way to bridge the gap between undiagnosed impairment and parental awareness. The cards were made available through the brand's own website rather than only in-store, extending distribution beyond the retail footprint.

GEMS Education partnership (UAE, 2025) institutional, school-based screening. In the UAE, Titan Eyeplus expanded a collaboration with GEMS Rewards, the loyalty programme of GEMS Education, from a two-school pilot to ten schools, offering free on-campus eye screening camps. Titan's international business CEO stated publicly that the pilot screening found approximately 33 percent of students required vision correction or consultation, with many showing symptoms linked to prolonged screen time, and that each flagged student received a personalised consultation and vision solution. This represents the brand's clearest institutional, B2B2C model for preventive screening using an existing school-parent relationship and loyalty infrastructure as the distribution channel rather than building awareness from a standing start.

Happy Eyes (2013–present) — the underlying CSR infrastructure. Distinct from these brand-led awareness campaigns, Titan Company has run "Happy Eyes" as a CSR initiative since 2013, delivered through partners including Sankara Eye Foundation, Narayana Nethralaya, and Drishti Eye Hospital, and covering programmes such as "Gift of Vision" (rural cataract surgery for the elderly), "Nanna Kannu" (paediatric screening in Karnataka government schools), the Mobile Rural Vision Project around Bengaluru, and permanent tele-ophthalmology "Vision Centres" in Tamil Nadu and Karnataka villages. According to the company's own sustainability disclosures, the programme has reached over 12 lakh (1.2 million) people through screening, refractive correction, and surgery since inception. Independent impact assessment reports commissioned by Titan including studies by the Social Audit Network and Deloitte Touche Tohmatsu India have evaluated specific components; one such report on Tamil Nadu and Karnataka operations documented that the programme reached 352,780 individuals through screening, with 21,061 people receiving glasses and 3,914 surgeries performed in the period covered. This CSR infrastructure predates and underpins the commercial awareness campaigns, giving Titan Eyeplus an operational eye-care delivery network clinicians, camps, and referral hospitals — that a purely marketing-led competitor would lack.

Positioning & Consumer Insight

Across these initiatives, the consistent consumer insight is that eye care in India suffers not primarily from lack of supply but from a behavioral and awareness failure: people do not self-identify as needing correction until impairment is severe, because vision loss is typically gradual and symptoms are normalized rather than acted upon. Titan Eyeplus's campaign architecture consistently responds to this by removing the "diagnosis" step as a precondition for action — bringing the test to the person (dhabas, schools, homes via digital tools, the night sky) rather than requiring the person to self-identify a problem and seek out a store. This is a deliberate departure from conventional eyewear marketing, which is typically built around product or fashion appeal to consumers who already know they need spectacles. By contrast, Titan Eyeplus's preventive-care communications position the brand as a public health educator first and a retailer second, using proprietary in-store diagnostic assets (the Duochrome test) and clinical partnerships (Sankara Eye Foundation, Narayana Nethralaya) to lend the "trusted expert" positioning credibility that a purely advertising-led claim would lack.

Media & Channel Strategy

Publicly available information confirms the following channel elements: digital video distribution featuring a Bollywood brand ambassador (2021); on-ground activation at non-retail, high-dwell-time locations such as highway dhabas (2024); creative and campaign development by Ogilvy and Ogilvy South across multiple initiatives; direct-to-consumer distribution of physical campaign material (the Ek Tara Test card) via the brand's own e-commerce website; and institutional partnership distribution through a school loyalty programme in the UAE. Trade and marketing publications such as Impact, Campaign Brief Asia, Best Media Info, and The Tribune covered these campaigns as earned media following press releases and agency announcements. No verified public information is available on paid media spend, planned reach targets across television or programmatic digital channels, or a formal integrated media plan for any of these campaigns; the public record documents creative concept, on-ground execution, and earned/press coverage, not a media buying strategy.

Business & Brand Outcomes

Documented, verifiable outcomes are narrower than campaign ambition and should be read as such. For the 2021 Duochrome initiative, the brand's own communications state an intent to screen 10 million people digitally within two months in pursuit of a world record; publicly available sources reviewed do not confirm whether this specific numeric target or record was ultimately achieved. For the 2024 Eye Test Menu, company-linked reporting states that over 7,000 drivers were screened across more than 900 locations since June 2024, against a stated ambition to reach 100,000 drivers through subsequent partnerships. For the Happy Eyes CSR programme, Titan's own sustainability disclosure states a cumulative reach of over 12 lakh people since 2013, and a Tamil Nadu/Karnataka-specific independent assessment documented 352,780 people screened, 21,061 glasses distributed, and 3,914 surgeries performed within the period that report covered.

At the divisional level, Titan's investor presentations report that the Eyecare Division recorded Total Income growth of 10 percent to approximately ₹796 crore in FY25, with sunglasses sales specifically noted as growing faster than the category average in Q4 FY25, and the division returning to double-digit growth in the second half of that fiscal year. These figures describe overall divisional performance and cannot be attributed specifically to any single awareness campaign, since Titan's public disclosures do not break out campaign-level sales impact, footfall conversion, or customer acquisition figures. No verified public information is available on the direct sales conversion, cost per screening, customer acquisition cost, or return on marketing investment attributable to the Duochrome, Eye Test Menu, Ek Tara Test, or GEMS Education initiatives specifically. No verified public information is available on independent, third-party audited confirmation of the stated statistics used in campaign communications (such as the "one in five children" or "one in three truck drivers" figures), beyond their attribution in press materials to named reports.

Strategic Implications

Titan Eyeplus's approach illustrates a recurring principle in category-building marketing for low-involvement health categories: where the core barrier to purchase is a lack of self-diagnosed need rather than product availability or price, the more effective marketing lever is often free or near-free screening infrastructure delivered at the point of the target audience's existing routine, rather than conventional product advertising. The brand's ability to run this strategy credibly rests on assets that took years to build and that a newer digital-first competitor could not easily replicate quickly a decade-plus CSR delivery network with clinical partners, in-house optometric expertise, and Tata Group–linked institutional trust. At the same time, the public record shows a consistent gap between the scale of stated campaign ambitions (world records, lakh-driver targets) and the scale of independently verifiable, completed outcomes reported in the same public sources, which is a common feature of cause-linked brand campaigns and a point worth scrutinizing rather than assuming away. The segment-by-segment architecture drivers, children, rural populations, urban self-screeners also suggests a deliberate strategy of building distinct, tailored "engagement mechanics" for each under-screened population rather than a single mass-market message, trading message consistency for relevance and distribution efficiency within each segment.

Discussion Questions

Titan Eyeplus repeatedly frames preventive screening as a public-health service rather than a sales funnel. What are the risks and benefits of this positioning choice for a company whose parent ultimately measures success through eyewear sales revenue?

The Eye Test Menu campaign targeted truck drivers specifically because of their occupational risk and low existing eye-care engagement. What criteria should a marketing team use to prioritize which under-screened segment to target next, given finite CSR and marketing resources?

Public sources confirm ambition-level targets (10 million screenings, 100,000 drivers) but not confirmed completion figures at that scale. As a marketing leader, how would you decide what to publicly commit to in a campaign announcement versus what to withhold until results are verified?

Titan Eyeplus draws credibility from a decade-old CSR infrastructure (Happy Eyes) built through hospital partnerships. How replicable is this kind of "trust asset" for a digital-first or newer entrant competing in the same preventive-care awareness space, and what alternative trust-building strategies might such a competitor pursue?

The brand uses different creative mechanics for different audiences — a celebrity-led digital test for urban consumers, a roadside "menu" for drivers, and a stargazing game for children. What does this suggest about the trade-offs between a unified brand campaign and a segmented, mechanic-specific campaign portfolio in preventive health marketing?